Chloroquine-induced vitiligo-like depigmentation

Annals of Tropical Paediatrics

Volumn 17, Issue 1, 1997, Pages 45-48

  Selvaag, Edgar ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

ARTICLE; ATOPIC DERMATITIS; CASE REPORT; DEPIGMENTATION; ETHIOPIA; FEMALE; HUMAN; MALARIA; PRESCHOOL CHILD; VITILIGO;

EID: 0031048531     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1080/02724936.1997.11747862     Document Type: Article

References (24)

1. Dall JLC, Keane JA. Disturbances of pigmentation with chloroquine. Br Med J 1959; I:1387-9.
2. Dupre A, Ortonne J-P, Viraben R, Arfeux F. Chloroquine-induced hypopigmentation of hair and freckles. Arch Dermatol 1985; 121:1164-6.
3. Bentsi-Enchill KO. Pigmentary skin changes associated with ocular chloroquine toxicity in Ghana. Trop Geogr Med 1980; 32:216-20.
4. Weelden H v, Bolling HH, Faille HBdL, Leun JCvd. Photosensitivity caused by chloroquine. Arch Dermatol 1982; 118:290.
5. Gonggryp LA, Kalla AA. Chloroquine-induced vitiligo in a patient with juvenile onset rheumatoid arthritis. Br J Rheumatol 1992; 31:790-1.
6. Bernstein HN. Chloroquine ocular toxicity. Survey Ophthalmol 1967; 12:415-47.
7. Dubois EL, Wallace DJ. Management of discoid and systemic lupus erythematosus. In: Wallace DJ, Dubois EL, eds. Dubois' Lupus Erythematosus. Philadelphia: Lea & Febiger, 1987; 501-64.
8. Sams WM, Epstein JH. The affinity of melanin for chloroquine. J Invest Dermatol 1965; 45:482-8.
9. Tjälve H, Nilsson M, Larsson B. Studies on the binding of chlorpromazine and chloroquine to melanin in vivo. Biochem Pharmacol 1981; 30:1845-7.
10. Bowness J, Morton R. The association of zinc and other metals with melanin and a melanin-protein complex. Biochem J 1953; 53:620.
11. Rubin M, Zvaifler N, Bernstein H, Mansour A. Chloroquine toxicity. In: Brodie B, Gillette J, eds. Drugs and Enzymes. Proceedings of the Second International Pharmacological Meeting. London: Pergamon Press, 1965;467.
12. Möller H. Pigmentary disturbances due to drugs. Acta Derm Venereol (Stockh) 1966; 46:423-31.
13. Saunders TS, Fitzpatrick TB, Seiji M, Brunet P, Rosenbaum EE. Decrease in human hair color and feather pigment of fowl following chloroquine diphosphate. J Invest Dermatol 1959; 33:87-90.
14. Sharvill DE. Bleaching of hair by chloroquine. Br Med J 1955; I:1035.
15. Marriott P, Borrie PF. Pigmentary changes following chloroquine. Proc R Soc Med 1975; 68:25-6.
16. Ochsendorf FR, Schäfer H, Runne U. Chlorquin-Überdosierung: bullöse Lichtreaktion, generalisiertes Ergrauen, Schwäche, Schwindel und Sehstörungen. Zentralbl Haut Geschl Krkh 1986; 152:661.
17. Ortel B, Sivayathorn A, Hönigsmann H. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy. Dermatologica 1989; 178:39-42.
18. Giglioli G, Djeting AE, Rutten FJ, Gnetle GHK. Photoallergic dermatitis during a chloroquine salt anti-malaria campaign in Guyana. Trans R Soc Trop Med Hyg 1967; 61:313.
19. Zabel R. Sehstörungen und Depigmentation des Kopfhaares nach überhöhter Chloroquindiphosphatmedikation. Aest Medizin 1968; 17:107-10.
20. Davids MJ, Ploeg DEvd. Acute porphyria and co-proporphyrinuria following chloroquine therapy. Arch Dermatol 1957; 75:796-800.
21. Banerjee AK, Sur Roy Chowdhury D. Mepacrine in vitiligo. Lancet 1965; I:1276.
22. Banerjee AK, Chowdhury DSR. Mepacrine and chloroquine in vitiligo. Bull Calcutta School Trop Med 1966; 14:21-2.
23. Alarcon-Segovia D. Repigmentation of vitiligo under penicillamine therapy for rheumatoid arthritis. Arch Dermatol 1982; 118:962.
24. Paul FM, Colbourne MJ. Chloroquine resistant malaria in children from a Chinese family in Pulau Tekong. Singapore Med J 1971; 12:147-53.